Clinical Trials

Carcinoma, Non-Small-Cell Lung

NCT03313804 2026-03-11

Priming Immunotherapy in Advanced Disease With Radiation

76 enrolled 9 charts

Head & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung

NCT04290546 2026-02-27

CIML NK Cell in Head & Neck Cancer

11 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT07192926 2026-02-20

SARCO-CTI

131 enrolled

Parkinson Disease 4, Autosomal Dominant Lewy Body, Carcinoma, Non-Small-Cell Lung, Neoplasms, Sarcopenia

NCT05166239 2026-01-23

HAIC Combine With Lenvatinib and PD-1 Inhibitors for Advanced HCC With PVTT

66 enrolled

Carcinoma, Hepatocellular

NCT05348668 2026-01-07

Hybrid Dose-fraction Radiotherapy for Metastatic Non-small Cell Lung Cancer

78 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05440916 2025-12-02

PRIMM

50 enrolled

Carcinoma, Non-Small-Cell Lung

NCT04417465 2025-09-25

First In Human Study With ABBV-CLS-579 When Given Alone and In Combination In Participants With Locally Advanced Or Metastatic Tumors

101 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Neoplasms

NCT04681131 2025-09-25

CAB-AXL-ADC Safety and Efficacy Study in Adults With NSCLC

85 enrolled

Carcinoma, Non-Small-Cell Lung, Neoplasms

NCT03425279 2025-09-23

CAB-AXL-ADC Safety and Efficacy Study in Adult and Adolescent Patients With Sarcoma

245 enrolled

Sarcoma

Neoplasms, Dermatofibrosarcoma, Histiocytoma, Malignant Fibrous

NCT05509699 2025-08-29

Surufatinib Plus Anti-PD-1/L1 as Maintenance Therapy in Extensive-Stage Small Cell Lung Cancer

21 enrolled

Small Cell Lung Carcinoma

NCT06980350 2025-07-29

Proposal of a Novel Model for Identifying Complete Response in dMMR Colon Cancer Following Neoadjuvant Immunotherapy

156 enrolled

Colorectal Neoplasms

NCT03984357 2025-07-17

PLATINUM

152 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT07036016 2025-06-25

Interstitial Pneumonitis Associated With EGFR-TKI and Combined With PD-1/PD-L1

67,818 enrolled

Carcinoma, Non-Small-Cell Lung

NCT07009600 2025-06-06

Conversion Surgery After Target Therapy or Immunotherapy in Stage IV Gastric Cancer

124 enrolled

Stomach Neoplasms

NCT06991907 2025-05-28

PD-1 Inhibitor Combined With 125I Seed Implantation for Hepatocellular Carcinoma's Extrahepatic Metastasis: Efficacy and Safety

Phase NA Completed

80 enrolled

Carcinoma, Hepatocellular

NCT03868046 2025-04-01

AUTENTIC

242 enrolled

Tumor-Agnostic

Neoplasm Metastasis, Neoplasms

NCT06900686 2025-03-28

Clinical Application of PD-1 Inhibitor in Colorectal Cancer for Improving Survival

458 enrolled

Parkinson Disease 4, Autosomal Dominant Lewy Body, Colonic Neoplasms, Rectal Neoplasms

NCT04997382 2025-02-25

CLASSIC5

112 enrolled

Carcinoma, Non-Small-Cell Lung

NCT03504488 2025-01-15

CAB-ROR2-ADC Safety and Efficacy Study in Patients With TNBC or Head & Neck Cancer (Ph1) and NSCLC or Melanoma (Ph2)

BreastDermatologicHead & NeckThoracic

132 enrolled

Carcinoma, Non-Small-Cell Lung, Head and Neck Neoplasms, Melanoma, Triple Negative Breast Neoplasms

NCT04020185 2024-12-11

Safety and Efficacy Study of IMSA101 in Refractory Malignancies

40 enrolled 16 charts

Other solid neoplasm

Solid Tumor, Adult

NCT03879512 2024-09-19

Autologous Dendritic Cells, Metronomic Cyclophosphamide and Checkpoint Blockade in Children With Relapsed HGG

24 enrolled

CNS

Astrocytoma, Glioma

NCT04721223 2024-09-19

JAB-3068 Activity in Adult Patients With Advanced Solid Tumors

GastrointestinalHead & NeckThoracic

12 enrolled

Squamous Cell Carcinoma of Head and Neck, Esophageal Squamous Cell Carcinoma, Carcinoma, Non-Small-Cell Lung

NCT03989336 2024-07-15

A Study of the Pan-immunotherapy in Patients With Relapsed/Refractory Ovarian Cancer

84 enrolled

Gynecologic

Ovarian Neoplasms, Recurrence

NCT03817736 2024-05-09

START-FIT

33 enrolled

Carcinoma, Hepatocellular, Liver Neoplasms

NCT05934214 2024-03-05

EXIT

141,630 enrolled

Tumor-Agnostic

Neoplasms

NCT03511391 2024-01-23

CHEERS

DermatologicGenitourinaryHead & NeckThoracic

99 enrolled

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Head and Neck Neoplasms, Melanoma

NCT04944888 2023-12-19

GSL Synthetase Inhibitor in Combination With Immune Checkpoint Inhibitor in Previously Treated Blood and Solid Tumor

Other hematologic neoplasm

31 enrolled

Hematologic Neoplasms

NCT06031376 2023-09-11

Fruquintinib With PD-1 Inhibitors Versus TAS-102 With Bevacizumab in Late-Line mCRC

106 enrolled

Colorectal Neoplasms

NCT06022692 2023-09-05

HEAIS001

18 enrolled

Hyperthermia, Digestive System Neoplasms

NCT06011330 2023-08-30

Fruquintinib Plus PD-1 in Refractory MSS Metastatic Colorectal Cancer

70 enrolled

Colorectal Neoplasms

NCT05942768 2023-07-12

Anti-PD-1 Antibody Plus Regorafenib in Refractory Microsatellite Stable Metastatic Colorectal Cancer

103 enrolled

Metastatic Colorectal Adenocarcinoma

NCT03790488 2023-07-03

Study of a PD-1 Inhibitor (JTX-4014) in Subjects With Solid Tumor Malignancies

18 enrolled

Tumor-Agnostic

Neoplasms

NCT05535998 2022-09-10

TACE-HAIC Combined With TKIs and Immunotherapy Versus TACE Alone for Hepatocellular Carcinoma With PVTT

743 enrolled

Carcinoma, Hepatocellular

NCT05307926 2022-09-07

Postoperative Adjuvant Therapy of HCC Based on PD-1

573 enrolled

Carcinoma, Hepatocellular

NCT05489692 2022-08-10

HAIC Plus Targeted Therapy and/or PD-1 Inhibitors for Unresectable Intrahepatic Cholangiocarcinoma

43 enrolled

Cholangiocarcinoma

NCT05326906 2022-05-16

The Prediction Biomarkers of Survival Outcome for Severe Immune-related Hepatitis

20 enrolled

Lung Neoplasms

NCT03492242 2019-09-26

CHIMeRA

1,000 enrolled

Arthritis, Autoimmune Diseases, Endocrine System Diseases, Eye Diseases, Heart Diseases, Myositis, Neoplasms

NCT02574533 2017-09-27

Pilot Study of Vigil™ + Pembrolizumab for Advanced Melanoma